Becton, Dickinson and Company logo

Becton, Dickinson and Company (BOX)

Market Open
2 Jul, 20:00
XBER XBER
150. 40
+5.1
+3.51%
63.87B Market Cap
- P/E Ratio
3.8% Div Yield
0 Volume
- Eps
145.3
Previous Close
Day Range
150.4 150.4
Year Range
145.1 239.6
Want to track BOX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 27 days

Summary

BOX trading today higher at €150.4, an increase of 3.51% from yesterday's close, completing a monthly increase of 0.3% or €0.45. Over the past 12 months, BOX stock lost -31.14%.
BOX pays dividends to its shareholders, with the most recent payment made on Jun 30, 2025. The next estimated payment will be in In 2 months on Sep 30, 2025 for a total of €1.04.
The last earnings report, released on May 01, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Jul 31, 2025.
Becton, Dickinson and Company has completed 5 stock splits, with the recent split occurring on Apr 01, 2022.
The company's stock is traded on 15 different exchanges and in various currencies, with the primary listing on NYSE (USD).

BOX Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.
3 Undervalued Dividend King Stocks With Over 50% Upside Potential

3 Undervalued Dividend King Stocks With Over 50% Upside Potential

As we enter the second half of 2025, now is the perfect time to invest in dividend stocks — especially those with quality underlying fundamentals that pay high dividend yields.

247wallst | 2 days ago
Becton, Dickinson and Company (BDX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)

Becton, Dickinson and Company (BDX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)

Becton, Dickinson and Company (NYSE:BDX ) Goldman Sachs 46th Annual Global Healthcare Conference June 9, 2025 2:00 PM ET Company Participants Thomas E. Polen - President, CEO & Chairman Conference Call Participants Robert Justin Marcus - JPMorgan Chase & Co, Research Division Unidentified Analyst Yes.

Seekingalpha | 3 weeks ago
Becton, Dickinson: A Dividend King Facing Challenges Offers Value

Becton, Dickinson: A Dividend King Facing Challenges Offers Value

Becton, Dickinson is significantly undervalued, trading at 12.3x earnings with a 2.5% dividend yield, the highest in a decade. The company boasts a 53-year streak of dividend growth, excellent dividend safety, and a conservative payout ratio, making it a reliable Dividend King. Despite tariff headwinds, competition, and restructuring risks, BDX's innovation, acquisitions, and organic growth support long-term revenue and EPS expansion.

Seekingalpha | 3 weeks ago

Becton, Dickinson and Company Dividends

Becton, Dickinson and Company logo
BOX 3 weeks ago
Other
€0.89 Per Share
Becton, Dickinson and Company logo
BOX 3 months ago
Other
€0.89 Per Share
Becton, Dickinson and Company logo
BOX 6 months ago
Other
€0.89 Per Share
Becton, Dickinson and Company logo
BOX 9 months ago
Other
€0.81 Per Share
Becton, Dickinson and Company logo
BOX 10 Jun 2024
Other
€0.81 Per Share

Becton, Dickinson and Company Earnings

7 Aug 2025 (In 1 month) Date
3.42
Cons. EPS
-
EPS
31 Jul 2025 (In 3 weeks) Date
-
Cons. EPS
-
EPS
1 May 2025 Date
-
Cons. EPS
-
EPS
30 Jan 2025 Date
-
Cons. EPS
-
EPS
7 Nov 2024 Date
-
Cons. EPS
-
EPS
Becton, Dickinson and Company logo
BOX 3 weeks ago
Other
€0.89 Per Share
Becton, Dickinson and Company logo
BOX 3 months ago
Other
€0.89 Per Share
Becton, Dickinson and Company logo
BOX 6 months ago
Other
€0.89 Per Share
Becton, Dickinson and Company logo
BOX 9 months ago
Other
€0.81 Per Share
Becton, Dickinson and Company logo
BOX 10 Jun 2024
Other
€0.81 Per Share
7 Aug 2025 (In 1 month) Date
3.42
Cons. EPS
-
EPS
31 Jul 2025 (In 3 weeks) Date
-
Cons. EPS
-
EPS
1 May 2025 Date
-
Cons. EPS
-
EPS
30 Jan 2025 Date
-
Cons. EPS
-
EPS
7 Nov 2024 Date
-
Cons. EPS
-
EPS

Becton, Dickinson and Company (BOX) FAQ

What is the stock price today?

The current price is €150.40.

On which exchange is it traded?

Becton, Dickinson and Company is listed on NYSE.

What is its stock symbol?

The ticker symbol is BOX.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 3.8%.

What is its market cap?

As of today, the market cap is 63.87B.

When is the next earnings date?

The next earnings report will release on Jul 31, 2025.

Has Becton, Dickinson and Company ever had a stock split?

Becton, Dickinson and Company had 5 splits and the recent split was on Apr 01, 2022.

Becton, Dickinson and Company Profile

Medical - Instruments & Supplies Industry
Healthcare Sector
Thomas E. Polen Jr. CEO
XBER Exchange
US0758871091 ISIN
US Country
70,000 Employees
10 Mar 2025 Last Dividend
1 Apr 2022 Last Split
- IPO Date

Overview

Becton, Dickinson and Company, commonly known as BD, is a global leader in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. Catering to healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public, BD operates worldwide. The company’s extensive product portfolio is strategically segmented into three core areas: BD Medical, BD Life Sciences, and BD Interventional. Founded in 1897, BD has established a robust presence in the healthcare sector, headquartered in Franklin Lakes, New Jersey.

Products and Services

  • BD Medical:

    This segment provides a comprehensive range of products, including peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, and vascular access technology. It also offers vascular care, preparation products, needle-free IV connectors, closed-system drug transfer devices, hazardous drug detections, and a variety of syringes and needles. For drug delivery and safety, it covers IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, as well as automated medication dispensing and supply management systems, enhancing medication inventory optimization and tracking. Additionally, BD Medical produces prefillable drug delivery systems.

  • BD Life Sciences:

    In this area, BD presents an array of solutions for specimen and blood collection and an extensive selection of diagnostic tools, including automated culturing for blood and tuberculosis, molecular testing systems, products for microorganism identification, and drug susceptibility testing. The segment also specializes in liquid-based cytology systems, rapid diagnostic assays, microbiology laboratory automation, and plated media products. For cellular analysis, it offers fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, crucial for clinical oncology, immunological research, and transplantation diagnostics or monitoring.

  • BD Interventional:

    BD's interventional segment covers a wide range of surgical and medical products, including those for hernia and soft tissue repair, biosurgery, and surgical infection prevention. It also offers biological and bioresorbable grafts, peripheral intervention products, and equipment for urology and critical care. These products are designed to improve patient outcomes and support the efficiency of medical procedures.

Contact Information

Address: 1 Becton Drive
Phone: 201 847 6800